# C_2010237EN.01000201.xml

| 2.9.2010 | EN | Official Journal of the European Union | C 237/2 |
| --- | --- | --- | --- |

2.9.2010

EN

Official Journal of the European Union

C 237/2

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2009

2010/C 237/02

Subcommittee I on the free movement of goods

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2009, at their meeting on 30 April 2010:

| Annex I | — | List of new marketing authorisations |
| --- | --- | --- |
| Annex II | — | List of renewed marketing authorisations |
| Annex III | — | List of extended marketing authorisations |
| Annex IV | — | List of withdrawn marketing authorisations |
| Annex V | — | List of suspended marketing authorisations |

Annex I

—

List of new marketing authorisations

Annex II

—

List of renewed marketing authorisations

Annex III

—

List of extended marketing authorisations

Annex IV

—

List of withdrawn marketing authorisations

Annex V

—

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2009:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/361/001/NO-002/NO | Luminity | Norway | 20.8.2009 |
| EU/1/07/436/001-002 | Isentress | Liechtenstein | 31.8.2009 |
| EU/1/09/575/001-060 | Copalia HCT | Liechtenstein | 31.12.2009 |
| EU/1/09/511/001-004 | Conbriza | Liechtenstein | 31.10.2009 |
| EU/1/09/515/001-004/IS | Controloc Control | Iceland | 7.9.2009 |
| EU/1/09/516/001/NO | Somac | Norway | 13.7.2009 |
| EU/1/09/516/001-004/IS | Somac Control | Iceland | 7.9.2009 |
| EU/1/09/516/002/NO | Pantoloc | Norway | 13.7.2009 |
| EU/1/09/516/003/NO | Pantecta | Norway | 13.7.2009 |
| EU/1/09/516/004/NO | Controloc | Norway | 13.7.2009 |
| EU/1/09/517/001/NO-002/NO | Pantozol | Norway | 9.7.2009 |
| EU/1/09/517/001-004/IS | Pantozol Control | Iceland | 7.9.2009 |
| EU/1/09/518/001-004/IS | Pantecta Control | Iceland | 7.9.2009 |
| EU/1/09/519/001-004/IS | Pantoloc Control | Iceland | 7.9.2009 |
| EU/1/09/521/001/NO-007/NO | Renvela | Norway | 7.10.2009 |
| EU/1/09/521/001-007/IS | Renvela | Iceland | 4.9.2009 |
| EU/1/09/523/001/NO-002/NO | Modigraf | Norway | 21.10.2009 |
| EU/1/09/523/001-002/IS | Modigraf | Iceland | 23.7.2009 |
| EU/1/09/524/001/NO-002/NO | Qutenza | Norway | 5.8.2009 |
| EU/1/09/524/001-002/IS | Qutenza | Iceland | 21.7.2009 |
| EU/1/09/525/001/NO-046/NO | Nimvastid | Norway | 2.11.2009 |
| EU/1/09/526/001/IS | Iressa | Iceland | 11.9.2009 |
| EU/1/09/526/001/NO | Iressa | Norway | 2.9.2009 |
| EU/1/09/527/001/NO-016/NO | Ribaverin Teva Pharma | Norway | 12.8.2009 |
| EU/1/09/527/001-016 | Ribavirin Teva Pharma BV | Liechtenstein | 31.8.2009 |
| EU/1/09/527/001-016/IS | Ribavirin Teva Pharma BV | Iceland | 17.9.2009 |
| EU/1/09/528/001 | Nymusa | Liechtenstein | 31.8.2009 |
| EU/1/09/528/001/IS | Nymusa | Iceland | 17.9.2009 |
| EU/1/09/528/001/NO | Nymusa | Norway | 12.8.2009 |
| EU/1/09/529/001/NO-005/NO | Victoza | Norway | 4.8.2009 |
| EU/1/09/529/001-005 | Victoza | Liechtenstein | 31.8.2009 |
| EU/1/09/529/001-005/IS | Victoza | Iceland | 15.9.2009 |
| EU/1/09/530/001/NO-015/NO | Repaglinide Teva | Norway | 12.8.2009 |
| EU/1/09/530/001-015 | Repaglinide Teva | Liechtenstein | 31.8.2009 |
| EU/1/09/530/001-015/IS | Repaglinide Teva | Iceland | 11.9.2009 |
| EU/1/09/531/001/NO-009/NO | Instanyl | Norway | 17.8.2009 |
| EU/1/09/531/001-009 | Instanyl | Liechtenstein | 31.8.2009 |
| EU/1/09/531/001-009/IS | Instanyl | Iceland | 24.9.2009 |
| EU/1/09/532/001/NO-007/NO | Clopidogrel Acino | Norway | 25.8.2009 |
| EU/1/09/532/001-007 | Clopidogrel Acino | Liechtenstein | 31.8.2009 |
| EU/1/09/532/001-007/IS | Clopidogrel Acino | Iceland | 24.9.2009 |
| EU/1/09/533/001/NO-003/NO | Vedrop | Norway | 20.8.2009 |
| EU/1/09/533/001-003 | Vedrop | Liechtenstein | 31.8.2009 |
| EU/1/09/533/001-003/IS | Vedrop | Iceland | 5.11.2009 |
| EU/1/09/534/001/NO-007/NO | Clopidogrel Hexal | Norway | 25.8.2009 |
| EU/1/09/534/001-007 | Clopidogrel Hexal | Liechtenstein | 31.8.2009 |
| EU/1/09/534/001-007/IS | Clopidogrel Hexal | Iceland | 28.9.2009 |
| EU/1/09/535/001/NO-014/NO | Grepid | Norway | 20.8.2009 |
| EU/1/09/535/001-014 | Grepid | Liechtenstein | 31.8.2009 |
| EU/1/09/535/001-014/IS | Grepid | Iceland | 9.9.2009 |
| EU/1/09/536/001/NO-002/NO | Topotecan Actavis | Norway | 26.8.2009 |
| EU/1/09/536/001-002 | Topotecan Actavis | Liechtenstein | 31.8.2009 |
| EU/1/09/536/001-002/IS | Topotecan Actavis | Iceland | 29.9.2009 |
| EU/1/09/537/001 | Mozobil | Liechtenstein | 31.8.2009 |
| EU/1/09/537/001/IS | Mozobil | Iceland | 14.10.2009 |
| EU/1/09/537/001/NO | Mozobil | Norway | 10.8.2009 |
| EU/1/09/538/001/NO-006/NO | Afinitor | Norway | 10.8.2009 |
| EU/1/09/538/001-006 | Afinitor | Liechtenstein | 31.8.2009 |
| EU/1/09/538/001-006/IS | Afinitor | Iceland | 15.10.2009 |
| EU/1/09/539/001/NO-004/NO | Samsca | Norway | 21.9.2009 |
| EU/1/09/539/001-004 | Samsca | Liechtenstein | 31.8.2009 |
| EU/1/09/539/001-004/IS | Samsca | Iceland | 22.9.2009 |
| EU/1/09/540/001/NO-009/NO | Clopidogrel Teva | Norway | 20.8.2009 |
| EU/1/09/540/001-009 | Clopidogrel Teva | Liechtenstein | 31.8.2009 |
| EU/1/09/540/001-009/IS | Clopidogrel Teva | Iceland | 29.9.2009 |
| EU/1/09/541/001/NO-007/NO | Clopidogrel ratiopharm GmbH | Norway | 20.8.2009 |
| EU/1/09/541/001-007 | Clopidogrel ratiopharm GmbH | Liechtenstein | 31.8.2009 |
| EU/1/09/541/001-007/IS | Clopidogrel ratiopharm GmbH | Iceland | 24.9.2009 |
| EU/1/09/542/001/NO-007/NO | Clopidogrel 1A Pharma | Norway | 20.8.2009 |
| EU/1/09/542/001-007 | Clopidogrel 1A Pharma | Liechtenstein | 31.8.2009 |
| EU/1/09/542/001-007/IS | Clopidogrel 1A Pharma | Iceland | 28.9.2009 |
| EU/1/09/543/001 | Cayston | Liechtenstein | 31.10.2009 |
| EU/1/09/543/001/IS | Cayston | Iceland | 9.11.2009 |
| EU/1/09/543/001/NO | Cayston | Norway | 30.9.2009 |
| EU/1/09/544/001/NO-002/NO | Cimzia | Norway | 21.10.2009 |
| EU/1/09/544/001-002 | Cimzia | Liechtenstein | 31.10.2009 |
| EU/1/09/544/001-002/IS | Cimzia | Iceland | 24.11.2009 |
| EU/1/09/545/001/NO-010/NO | Onglyza | Norway | 8.10.2009 |
| EU/1/09/545/001-010 | Onglyza | Liechtenstein | 31.10.2009 |
| EU/1/09/545/001-010/IS | Onglyza | Iceland | 12.11.2009 |
| EU/1/09/546/001/NO-004/NO | Simponi | Norway | 16.10.2009 |
| EU/1/09/546/001-004 | Simponi | Liechtenstein | 31.10.2009 |
| EU/1/09/546/001-004/IS | Simponi | Iceland | 2.11.2009 |
| EU/1/09/547/001/NO-007/NO | Clopidogrel Sandoz | Norway | 15.10.2009 |
| EU/1/09/547/001-007 | Clopidogrel Sandoz | Liechtenstein | 31.10.2009 |
| EU/1/09/547/001-007/IS | Clopidogrel Sandoz | Iceland | 25.9.2009 |
| EU/1/09/548/001/NO-007/NO | Clopidogrel Acino Pharma GmbH | Norway | 16.11.2009 |
| EU/1/09/548/001-007 | Clopidogrel Acino Pharma GmbH | Liechtenstein | 31.10.2009 |
| EU/1/09/548/001-007/IS | Clopidogrel Acino Pharma GmbH | Iceland | 24.9.2009 |
| EU/1/09/549/001/NO-007/NO | Clopidogrel Acino Pharma | Norway | 16.11.2009 |
| EU/1/09/549/001-007 | Clopidogrel Acino Pharma | Liechtenstein | 31.10.2009 |
| EU/1/09/549/001-007/IS | Clopidogrel Acino Pharma | Iceland | 30.11.2009 |
| EU/1/09/550/001/NO-012/NO | Javlor | Norway | 21.10.2009 |
| EU/1/09/550/001-012 | Javlor | Liechtenstein | 31.10.2009 |
| EU/1/09/550/001-012/IS | Javlor | Iceland | 10.11.2009 |
| EU/1/09/551/001/NO-012/NO | Vizarsin | Norway | 30.9.2009 |
| EU/1/09/551/001-012 | Vizarsin | Liechtenstein | 31.10.2009 |
| EU/1/09/551/001-012/IS | Vizarsin | Iceland | 6.11.2009 |
| EU/1/09/552/001/NO-004/NO | Topotecan Teva | Norway | 21.10.2009 |
| EU/1/09/552/001-004 | Topotecan Teva | Liechtenstein | 31.10.2009 |
| EU/1/09/552/001-004/IS | Topotecan Teva | Iceland | 10.11.2009 |
| EU/1/09/553/001/NO-010/NO | Zyllt | Norway | 15.10.2009 |
| EU/1/09/553/001-010 | Zyllit | Liechtenstein | 31.10.2009 |
| EU/1/09/553/001-010/IS | Zyllt | Iceland | 5.11.2009 |
| EU/1/09/554/001/NO-007/NO | Clopidogrel ratiopharm | Norway | 28.10.2009 |
| EU/1/09/554/001-007 | Clopidogrel ratiopharm | Liechtenstein | 31.10.2009 |
| EU/1/09/554/001-007/IS | Clopidogrel ratiopharm | Iceland | 27.11.2009 |
| EU/1/09/555/001/NO-009/NO | Clopidogrel TAD | Norway | 15.10.2009 |
| EU/1/09/555/001-009 | Clopidogrel TAD | Liechtenstein | 31.10.2009 |
| EU/1/09/555/001-009/IS | Clopidogrel TAD | Iceland | 2.12.2009 |
| EU/1/09/556/001/NO-009/NO | Clopidogrel Krka | Norway | 15.10.2009 |
| EU/1/09/556/001-009 | Clopidogrel Krka | Liechtenstein | 31.10.2009 |
| EU/1/09/556/001-009/IS | Clopidogrel Krka | Iceland | 17.11.2009 |
| EU/1/09/557/001/NO-009/NO | Clopidogrel Qualimed | Norway | 15.10.2009 |
| EU/1/09/557/001-009 | Clopidogrel Qualimed | Liechtenstein | 31.10.2009 |
| EU/1/09/557/001-009/IS | Clopidogrel Qualimed | Iceland | 3.11.2009 |
| EU/1/09/558/001/NO-010/NO | Zylagren | Norway | 30.9.2009 |
| EU/1/09/558/001-010 | Zylagren | Liechtenstein | 31.10.2009 |
| EU/1/09/558/001-010/IS | Zylagren | Iceland | 5.11.2009 |
| EU/1/09/559/001/NO-009/NO | Clopidogrel Mylan | Norway | 15.10.2009 |
| EU/1/09/559/001-009 | Clopidogrel Mylan | Liechtenstein | 31.10.2009 |
| EU/1/09/559/001-009/IS | Clopidogrel Mylan | Iceland | 29.9.2009 |
| EU/1/09/560/001/NO-009/NO | Clopidogrel Dura | Norway | 15.10.2009 |
| EU/1/09/560/001-009 | Clopidogrel Dura | Liechtenstein | 31.10.2009 |
| EU/1/09/560/001-009/IS | Clopidogrel Dura | Iceland | 2.11.2009 |
| EU/1/09/561/001/NO-009/NO | Clopidogrel HCS | Norway | 15.10.2009 |
| EU/1/09/561/001-009 | Clopidogrel HCS | Liechtenstein | 31.10.2009 |
| EU/1/09/561/001-009/IS | Clopidogrel HCS | Iceland | 3.11.2009 |
| EU/1/09/562/001/NO-009/NO | Zopya | Norway | 30.9.2009 |
| EU/1/09/562/001-009 | Zopya | Liechtenstein | 31.10.2009 |
| EU/1/09/562/001-009/IS | Zopya | Iceland | 3.11.2009 |
| EU/1/09/563/001 | ChondroCelect | Liechtenstein | 31.10.2009 |
| EU/1/09/563/001/IS | ChondroCelect | Iceland | 30.11.2009 |
| EU/1/09/563/001/NO | ChondroCelect | Norway | 22.10.2009 |
| EU/1/09/564/001/NO-002/NO | Ilaris | Norway | 10.11.2009 |
| EU/1/09/564/001-002 | Ilaris | Liechtenstein | 31.10.2009 |
| EU/1/09/564/001-002/IS | Ilaris | Iceland | 20.11.2009 |
| EU/1/09/565/001/NO-028/NO | Biopoin | Norway | 11.11.2009 |
| EU/1/09/565/001-028 | Biopoin | Liechtenstein | 31.10.2009 |
| EU/1/09/565/001-028/IS | Biopoin | Iceland | 20.11.2009 |
| EU/1/09/566/001/NO-005/NO | Lamivudine Teva | Norway | 16.11.2009 |
| EU/1/09/566/001-005 | Lamivudine Teva | Liechtenstein | 31.10.2009 |
| EU/1/09/566/001-005/IS | Lamivudine Teva | Iceland | 20.11.2009 |
| EU/1/09/568/001/NO-018/NO | Klopidogrel Mylan Pharma | Norway | 16.11.2009 |
| EU/1/09/568/001-018 | Clopidogrel Mylan Pharma | Liechtenstein | 31.10.2009 |
| EU/1/09/568/001-018/IS | Clopidogrel Mylan Pharma | Iceland | 27.11.2009 |
| EU/1/09/569/001/NO-060/NO | Exforge HCT | Norway | 2.11.2009 |
| EU/1/09/569/001-060 | Exforge HCT | Liechtenstein | 31.10.2009 |
| EU/1/09/569/001-060/IS | Exforge HCT | Iceland | 18.11.2009 |
| EU/1/09/570/001/NO-060/NO | Imprida HCT | Norway | 24.11.2009 |
| EU/1/09/570/001-060 | Imprida HCT | Liechtenstein | 31.10.2009 |
| EU/1/09/570/001-060/IS | Imprida HCT | Iceland | 18.11.2009 |
| EU/1/09/571/001 | Pandemic Influenza Vaccine H5N1 Baxter | Liechtenstein | 31.12.2009 |
| EU/1/09/571/001/NO | Pandemic Influenza Vaccine H5N1 Baxter | Norway | 2.12.2009 |
| EU/1/09/572/001/NO-009/NO | Alendronate Sodium and Colecalciferol MSD | Norway | 14.12.2009 |
| EU/1/09/572/001-009 | Alendronate Sodium and Colecalciferol MSD | Liechtenstein | 31.10.2009 |
| EU/1/09/572/001-009/IS | Alendronate Sodium and Colecalciferol MSD | Iceland | 26.11.2009 |
| EU/1/09/573/001/NO-028/NO | Eporatio | Norway | 11.11.2009 |
| EU/1/09/573/001-028 | Eporatio | Liechtenstein | 31.12.2009 |
| EU/1/09/573/001-028/IS | Eporatio | Iceland | 20.11.2009 |
| EU/1/09/574/001/NO-060/NO | Dafiro HCT | Norway | 25.11.2009 |
| EU/1/09/574/001-060 | Dafiro HCT | Liechtenstein | 31.12.2009 |
| EU/1/09/574/001-060/IS | Dafiro HCT | Iceland | 25.11.2009 |
| EU/1/09/575/001/NO-060/NO | Copalia | Norway | 25.11.2009 |
| EU/1/09/575/001-060/IS | Copalia HCT | Iceland | 26.11.2009 |
| EU/1/09/576/001/NO-039/NO | Irbesartan Teva | Norway | 11.11.2009 |
| EU/1/09/576/001-039 | Irbesartan Teva | Liechtenstein | 31.12.2009 |
| EU/1/09/576/001-039/IS | Irbesartan Teva | Iceland | 25.11.2009 |
| EU/1/09/577/001-004 | Foclivia | Liechtenstein | 31.12.2009 |
| EU/1/09/578/001 | Pandemic Influenza Vaccine (H5N1) GlaxoSmithKline Biologicals | Liechtenstein | 31.12.2009 |
| EU/1/09/578/001/NO | Pandemivaksine mot influensa | Norway | 1.12.2009 |
| EU/1/09/579/001/NO-018/NO | Repaglinide Krka | Norway | 10.12.2009 |
| EU/1/09/579/001-018 | Repaglinide Krka | Liechtenstein | 31.12.2009 |
| EU/1/09/579/001-018/IS | Repaglinide Krka | Iceland | 17.11.2009 |
| EU/1/09/580/001/NO-018/NO | Enyglid | Norway | 13.11.2009 |
| EU/1/09/580/001-018 | Enyglid | Liechtenstein | 31.10.2009 |
| EU/1/09/580/001-018/IS | Enyglid | Iceland | 17.11.2009 |
| EU/1/09/581/001/NO-002/NO | Resolor | Norway | 14.12.2009 |
| EU/1/09/581/001-002 | Resolor | Liechtenstein | 31.10.2009 |
| EU/1/09/581/001-002/IS | Resolor | Iceland | 18.11.2009 |
| EU/1/09/582/001 | Arcalyst | Liechtenstein | 31.10.2009 |
| EU/1/09/582/001/IS | Arcalyst | Iceland | 20.11.2009 |
| EU/1/09/582/001/NO | Arcalyst | Norway | 11.11.2009 |
| EU/1/09/583/001-072/IS | Irbesartan/Hydrochlorothiazide Teva | Iceland | 17.12.2009 |
| EU/1/09/584/001/NO-018/NO | Sildenafil Teva | Norway | 15.12.2009 |
| EU/1/09/584/001-018/IS | Sildenafil Teva | Iceland | 23.12.2009 |
| EU/1/09/586/001-010/IS | Oslif Breezhaler | Iceland | 22.12.2009 |
| EU/1/09/590/001-006/IS | Prevenar 13 | Iceland | 16.12.2009 |
| EU/1/09/591/001/NO-004/NO | Multaq | Norway | 15.12.2009 |
| EU/1/09/591/001-004/IS | Multaq | Iceland | 21.12.2009 |
| EU/1/09/593/001-010/IS | Onbrez Breezhaler | Iceland | 22.12.2009 |
| EU/1/09/594/001-010/IS | Hirobriz Breezhaler | Iceland | 22.12.2009 |
| EU/1/97/045/001/NO-004/NO | Helicobacter Test INFAI | Norway | 21.9.2009 |
| EU/2/07/076/001-004/IS | Nobilis Influenza H5N6 | Iceland | 7.9.2009 |
| EU/2/08/083/001/IS | Equioxx | Iceland | 21.7.2009 |
| EU/2/08/086/001-003/IS | Duvaxyn WNV | Iceland | 4.11.2009 |
| EU/2/09/095/001-003/IS | Improvac | Iceland | 3.11.2009 |
| EU/2/09/096/001-002/IS | Leucogen | Iceland | 11.9.2009 |
| EU/2/09/097/001/NO-002/NO | Leucofeligen FeLV/RCP | Norway | 13.7.2009 |
| EU/2/09/097/001-002 | Leucofeligen FeLV/RCP | Liechtenstein | 31.8.2009 |
| EU/2/09/097/001-002/IS | Leucofeligen FeLV/RCP | Iceland | 11.9.2009 |
| EU/2/09/098/001 | Melovem | Liechtenstein | 31.8.2009 |
| EU/2/09/098/001/IS | Melovem | Iceland | 22.9.2009 |
| EU/2/09/098/001/NO | Melovem | Norway | 4.9.2009 |
| EU/2/09/099/001/NO-006/NO | Suvaxyn PCV vet | Norway | 18.8.2009 |
| EU/2/09/099/001-006 | Suvaxyn PCV | Liechtenstein | 31.8.2009 |
| EU/2/09/099/001-006/IS | Suvaxyn PCV | Iceland | 28.9.2009 |
| EU/2/09/100/001/NO-003/NO | Palladia | Norway | 29.10.2009 |
| EU/2/09/100/001-003 | Palladia | Liechtenstein | 31.10.2009 |
| EU/2/09/100/001-003/IS | Palladia | Iceland | 11.11.2009 |

EU-Number

Product

Country

Date of authorisation

EU/1/06/361/001/NO-002/NO

Luminity

Norway

20.8.2009

EU/1/07/436/001-002

Isentress

Liechtenstein

31.8.2009

EU/1/09/575/001-060

Copalia HCT

Liechtenstein

31.12.2009

EU/1/09/511/001-004

Conbriza

Liechtenstein

31.10.2009

EU/1/09/515/001-004/IS

Controloc Control

Iceland

7.9.2009

EU/1/09/516/001/NO

Somac

Norway

13.7.2009

EU/1/09/516/001-004/IS

Somac Control

Iceland

7.9.2009

EU/1/09/516/002/NO

Pantoloc

Norway

13.7.2009

EU/1/09/516/003/NO

Pantecta

Norway

13.7.2009

EU/1/09/516/004/NO

Controloc

Norway

13.7.2009

EU/1/09/517/001/NO-002/NO

Pantozol

Norway

9.7.2009

EU/1/09/517/001-004/IS

Pantozol Control

Iceland

7.9.2009

EU/1/09/518/001-004/IS

Pantecta Control

Iceland

7.9.2009

EU/1/09/519/001-004/IS

Pantoloc Control

Iceland

7.9.2009

EU/1/09/521/001/NO-007/NO

Renvela

Norway

7.10.2009

EU/1/09/521/001-007/IS

Renvela

Iceland

4.9.2009

EU/1/09/523/001/NO-002/NO

Modigraf

Norway

21.10.2009

EU/1/09/523/001-002/IS

Modigraf

Iceland

23.7.2009

EU/1/09/524/001/NO-002/NO

Qutenza

Norway

5.8.2009

EU/1/09/524/001-002/IS

Qutenza

Iceland

21.7.2009

EU/1/09/525/001/NO-046/NO

Nimvastid

Norway

2.11.2009

EU/1/09/526/001/IS

Iressa

Iceland

11.9.2009

EU/1/09/526/001/NO

Iressa

Norway

2.9.2009

EU/1/09/527/001/NO-016/NO

Ribaverin Teva Pharma

Norway

12.8.2009

EU/1/09/527/001-016

Ribavirin Teva Pharma BV

Liechtenstein

31.8.2009

EU/1/09/527/001-016/IS

Ribavirin Teva Pharma BV

Iceland

17.9.2009

EU/1/09/528/001

Nymusa

Liechtenstein

31.8.2009

EU/1/09/528/001/IS

Nymusa

Iceland

17.9.2009

EU/1/09/528/001/NO

Nymusa

Norway

12.8.2009

EU/1/09/529/001/NO-005/NO

Victoza

Norway

4.8.2009

EU/1/09/529/001-005

Victoza

Liechtenstein

31.8.2009

EU/1/09/529/001-005/IS

Victoza

Iceland

15.9.2009

EU/1/09/530/001/NO-015/NO

Repaglinide Teva

Norway

12.8.2009

EU/1/09/530/001-015

Repaglinide Teva

Liechtenstein

31.8.2009

EU/1/09/530/001-015/IS

Repaglinide Teva

Iceland

11.9.2009

EU/1/09/531/001/NO-009/NO

Instanyl

Norway

17.8.2009

EU/1/09/531/001-009

Instanyl

Liechtenstein

31.8.2009

EU/1/09/531/001-009/IS

Instanyl

Iceland

24.9.2009

EU/1/09/532/001/NO-007/NO

Clopidogrel Acino

Norway

25.8.2009

EU/1/09/532/001-007

Clopidogrel Acino

Liechtenstein

31.8.2009

EU/1/09/532/001-007/IS

Clopidogrel Acino

Iceland

24.9.2009

EU/1/09/533/001/NO-003/NO

Vedrop

Norway

20.8.2009

EU/1/09/533/001-003

Vedrop

Liechtenstein

31.8.2009

EU/1/09/533/001-003/IS

Vedrop

Iceland

5.11.2009

EU/1/09/534/001/NO-007/NO

Clopidogrel Hexal

Norway

25.8.2009

EU/1/09/534/001-007

Clopidogrel Hexal

Liechtenstein

31.8.2009

EU/1/09/534/001-007/IS

Clopidogrel Hexal

Iceland

28.9.2009

EU/1/09/535/001/NO-014/NO

Grepid

Norway

20.8.2009

EU/1/09/535/001-014

Grepid

Liechtenstein

31.8.2009

EU/1/09/535/001-014/IS

Grepid

Iceland

9.9.2009

EU/1/09/536/001/NO-002/NO

Topotecan Actavis

Norway

26.8.2009

EU/1/09/536/001-002

Topotecan Actavis

Liechtenstein

31.8.2009

EU/1/09/536/001-002/IS

Topotecan Actavis

Iceland

29.9.2009

EU/1/09/537/001

Mozobil

Liechtenstein

31.8.2009

EU/1/09/537/001/IS

Mozobil

Iceland

14.10.2009

EU/1/09/537/001/NO

Mozobil

Norway

10.8.2009

EU/1/09/538/001/NO-006/NO

Afinitor

Norway

10.8.2009

EU/1/09/538/001-006

Afinitor

Liechtenstein

31.8.2009

EU/1/09/538/001-006/IS

Afinitor

Iceland

15.10.2009

EU/1/09/539/001/NO-004/NO

Samsca

Norway

21.9.2009

EU/1/09/539/001-004

Samsca

Liechtenstein

31.8.2009

EU/1/09/539/001-004/IS

Samsca

Iceland

22.9.2009

EU/1/09/540/001/NO-009/NO

Clopidogrel Teva

Norway

20.8.2009

EU/1/09/540/001-009

Clopidogrel Teva

Liechtenstein

31.8.2009

EU/1/09/540/001-009/IS

Clopidogrel Teva

Iceland

29.9.2009

EU/1/09/541/001/NO-007/NO

Clopidogrel ratiopharm GmbH

Norway

20.8.2009

EU/1/09/541/001-007

Clopidogrel ratiopharm GmbH

Liechtenstein

31.8.2009

EU/1/09/541/001-007/IS

Clopidogrel ratiopharm GmbH

Iceland

24.9.2009

EU/1/09/542/001/NO-007/NO

Clopidogrel 1A Pharma

Norway

20.8.2009

EU/1/09/542/001-007

Clopidogrel 1A Pharma

Liechtenstein

31.8.2009

EU/1/09/542/001-007/IS

Clopidogrel 1A Pharma

Iceland

28.9.2009

EU/1/09/543/001

Cayston

Liechtenstein

31.10.2009

EU/1/09/543/001/IS

Cayston

Iceland

9.11.2009

EU/1/09/543/001/NO

Cayston

Norway

30.9.2009

EU/1/09/544/001/NO-002/NO

Cimzia

Norway

21.10.2009

EU/1/09/544/001-002

Cimzia

Liechtenstein

31.10.2009

EU/1/09/544/001-002/IS

Cimzia

Iceland

24.11.2009

EU/1/09/545/001/NO-010/NO

Onglyza

Norway

8.10.2009

EU/1/09/545/001-010

Onglyza

Liechtenstein

31.10.2009

EU/1/09/545/001-010/IS

Onglyza

Iceland

12.11.2009

EU/1/09/546/001/NO-004/NO

Simponi

Norway

16.10.2009

EU/1/09/546/001-004

Simponi

Liechtenstein

31.10.2009

EU/1/09/546/001-004/IS

Simponi

Iceland

2.11.2009

EU/1/09/547/001/NO-007/NO

Clopidogrel Sandoz

Norway

15.10.2009

EU/1/09/547/001-007

Clopidogrel Sandoz

Liechtenstein

31.10.2009

EU/1/09/547/001-007/IS

Clopidogrel Sandoz

Iceland

25.9.2009

EU/1/09/548/001/NO-007/NO

Clopidogrel Acino Pharma GmbH

Norway

16.11.2009

EU/1/09/548/001-007

Clopidogrel Acino Pharma GmbH

Liechtenstein

31.10.2009

EU/1/09/548/001-007/IS

Clopidogrel Acino Pharma GmbH

Iceland

24.9.2009

EU/1/09/549/001/NO-007/NO

Clopidogrel Acino Pharma

Norway

16.11.2009

EU/1/09/549/001-007

Clopidogrel Acino Pharma

Liechtenstein

31.10.2009

EU/1/09/549/001-007/IS

Clopidogrel Acino Pharma

Iceland

30.11.2009

EU/1/09/550/001/NO-012/NO

Javlor

Norway

21.10.2009

EU/1/09/550/001-012

Javlor

Liechtenstein

31.10.2009

EU/1/09/550/001-012/IS

Javlor

Iceland

10.11.2009

EU/1/09/551/001/NO-012/NO

Vizarsin

Norway

30.9.2009

EU/1/09/551/001-012

Vizarsin

Liechtenstein

31.10.2009

EU/1/09/551/001-012/IS

Vizarsin

Iceland

6.11.2009

EU/1/09/552/001/NO-004/NO

Topotecan Teva

Norway

21.10.2009

EU/1/09/552/001-004

Topotecan Teva

Liechtenstein

31.10.2009

EU/1/09/552/001-004/IS

Topotecan Teva

Iceland

10.11.2009

EU/1/09/553/001/NO-010/NO

Zyllt

Norway

15.10.2009

EU/1/09/553/001-010

Zyllit

Liechtenstein

31.10.2009

EU/1/09/553/001-010/IS

Zyllt

Iceland

5.11.2009

EU/1/09/554/001/NO-007/NO

Clopidogrel ratiopharm

Norway

28.10.2009

EU/1/09/554/001-007

Clopidogrel ratiopharm

Liechtenstein

31.10.2009

EU/1/09/554/001-007/IS

Clopidogrel ratiopharm

Iceland

27.11.2009

EU/1/09/555/001/NO-009/NO

Clopidogrel TAD

Norway

15.10.2009

EU/1/09/555/001-009

Clopidogrel TAD

Liechtenstein

31.10.2009

EU/1/09/555/001-009/IS

Clopidogrel TAD

Iceland

2.12.2009

EU/1/09/556/001/NO-009/NO

Clopidogrel Krka

Norway

15.10.2009

EU/1/09/556/001-009

Clopidogrel Krka

Liechtenstein

31.10.2009

EU/1/09/556/001-009/IS

Clopidogrel Krka

Iceland

17.11.2009

EU/1/09/557/001/NO-009/NO

Clopidogrel Qualimed

Norway

15.10.2009

EU/1/09/557/001-009

Clopidogrel Qualimed

Liechtenstein

31.10.2009

EU/1/09/557/001-009/IS

Clopidogrel Qualimed

Iceland

3.11.2009

EU/1/09/558/001/NO-010/NO

Zylagren

Norway

30.9.2009

EU/1/09/558/001-010

Zylagren

Liechtenstein

31.10.2009

EU/1/09/558/001-010/IS

Zylagren

Iceland

5.11.2009

EU/1/09/559/001/NO-009/NO

Clopidogrel Mylan

Norway

15.10.2009

EU/1/09/559/001-009

Clopidogrel Mylan

Liechtenstein

31.10.2009

EU/1/09/559/001-009/IS

Clopidogrel Mylan

Iceland

29.9.2009

EU/1/09/560/001/NO-009/NO

Clopidogrel Dura

Norway

15.10.2009

EU/1/09/560/001-009

Clopidogrel Dura

Liechtenstein

31.10.2009

EU/1/09/560/001-009/IS

Clopidogrel Dura

Iceland

2.11.2009

EU/1/09/561/001/NO-009/NO

Clopidogrel HCS

Norway

15.10.2009

EU/1/09/561/001-009

Clopidogrel HCS

Liechtenstein

31.10.2009

EU/1/09/561/001-009/IS

Clopidogrel HCS

Iceland

3.11.2009

EU/1/09/562/001/NO-009/NO

Zopya

Norway

30.9.2009

EU/1/09/562/001-009

Zopya

Liechtenstein

31.10.2009

EU/1/09/562/001-009/IS

Zopya

Iceland

3.11.2009

EU/1/09/563/001

ChondroCelect

Liechtenstein

31.10.2009

EU/1/09/563/001/IS

ChondroCelect

Iceland

30.11.2009

EU/1/09/563/001/NO

ChondroCelect

Norway

22.10.2009

EU/1/09/564/001/NO-002/NO

Ilaris

Norway

10.11.2009

EU/1/09/564/001-002

Ilaris

Liechtenstein

31.10.2009

EU/1/09/564/001-002/IS

Ilaris

Iceland

20.11.2009

EU/1/09/565/001/NO-028/NO

Biopoin

Norway

11.11.2009

EU/1/09/565/001-028

Biopoin

Liechtenstein

31.10.2009

EU/1/09/565/001-028/IS

Biopoin

Iceland

20.11.2009

EU/1/09/566/001/NO-005/NO

Lamivudine Teva

Norway

16.11.2009

EU/1/09/566/001-005

Lamivudine Teva

Liechtenstein

31.10.2009

EU/1/09/566/001-005/IS

Lamivudine Teva

Iceland

20.11.2009

EU/1/09/568/001/NO-018/NO

Klopidogrel Mylan Pharma

Norway

16.11.2009

EU/1/09/568/001-018

Clopidogrel Mylan Pharma

Liechtenstein

31.10.2009

EU/1/09/568/001-018/IS

Clopidogrel Mylan Pharma

Iceland

27.11.2009

EU/1/09/569/001/NO-060/NO

Exforge HCT

Norway

2.11.2009

EU/1/09/569/001-060

Exforge HCT

Liechtenstein

31.10.2009

EU/1/09/569/001-060/IS

Exforge HCT

Iceland

18.11.2009

EU/1/09/570/001/NO-060/NO

Imprida HCT

Norway

24.11.2009

EU/1/09/570/001-060

Imprida HCT

Liechtenstein

31.10.2009

EU/1/09/570/001-060/IS

Imprida HCT

Iceland

18.11.2009

EU/1/09/571/001

Pandemic Influenza Vaccine H5N1 Baxter

Liechtenstein

31.12.2009

EU/1/09/571/001/NO

Pandemic Influenza Vaccine H5N1 Baxter

Norway

2.12.2009

EU/1/09/572/001/NO-009/NO

Alendronate Sodium and Colecalciferol MSD

Norway

14.12.2009

EU/1/09/572/001-009

Alendronate Sodium and Colecalciferol MSD

Liechtenstein

31.10.2009

EU/1/09/572/001-009/IS

Alendronate Sodium and Colecalciferol MSD

Iceland

26.11.2009

EU/1/09/573/001/NO-028/NO

Eporatio

Norway

11.11.2009

EU/1/09/573/001-028

Eporatio

Liechtenstein

31.12.2009

EU/1/09/573/001-028/IS

Eporatio

Iceland

20.11.2009

EU/1/09/574/001/NO-060/NO

Dafiro HCT

Norway

25.11.2009

EU/1/09/574/001-060

Dafiro HCT

Liechtenstein

31.12.2009

EU/1/09/574/001-060/IS

Dafiro HCT

Iceland

25.11.2009

EU/1/09/575/001/NO-060/NO

Copalia

Norway

25.11.2009

EU/1/09/575/001-060/IS

Copalia HCT

Iceland

26.11.2009

EU/1/09/576/001/NO-039/NO

Irbesartan Teva

Norway

11.11.2009

EU/1/09/576/001-039

Irbesartan Teva

Liechtenstein

31.12.2009

EU/1/09/576/001-039/IS

Irbesartan Teva

Iceland

25.11.2009

EU/1/09/577/001-004

Foclivia

Liechtenstein

31.12.2009

EU/1/09/578/001

Pandemic Influenza Vaccine (H5N1) GlaxoSmithKline Biologicals

Liechtenstein

31.12.2009

EU/1/09/578/001/NO

Pandemivaksine mot influensa

Norway

1.12.2009

EU/1/09/579/001/NO-018/NO

Repaglinide Krka

Norway

10.12.2009

EU/1/09/579/001-018

Repaglinide Krka

Liechtenstein

31.12.2009

EU/1/09/579/001-018/IS

Repaglinide Krka

Iceland

17.11.2009

EU/1/09/580/001/NO-018/NO

Enyglid

Norway

13.11.2009

EU/1/09/580/001-018

Enyglid

Liechtenstein

31.10.2009

EU/1/09/580/001-018/IS

Enyglid

Iceland

17.11.2009

EU/1/09/581/001/NO-002/NO

Resolor

Norway

14.12.2009

EU/1/09/581/001-002

Resolor

Liechtenstein

31.10.2009

EU/1/09/581/001-002/IS

Resolor

Iceland

18.11.2009

EU/1/09/582/001

Arcalyst

Liechtenstein

31.10.2009

EU/1/09/582/001/IS

Arcalyst

Iceland

20.11.2009

EU/1/09/582/001/NO

Arcalyst

Norway

11.11.2009

EU/1/09/583/001-072/IS

Irbesartan/Hydrochlorothiazide Teva

Iceland

17.12.2009

EU/1/09/584/001/NO-018/NO

Sildenafil Teva

Norway

15.12.2009

EU/1/09/584/001-018/IS

Sildenafil Teva

Iceland

23.12.2009

EU/1/09/586/001-010/IS

Oslif Breezhaler

Iceland

22.12.2009

EU/1/09/590/001-006/IS

Prevenar 13

Iceland

16.12.2009

EU/1/09/591/001/NO-004/NO

Multaq

Norway

15.12.2009

EU/1/09/591/001-004/IS

Multaq

Iceland

21.12.2009

EU/1/09/593/001-010/IS

Onbrez Breezhaler

Iceland

22.12.2009

EU/1/09/594/001-010/IS

Hirobriz Breezhaler

Iceland

22.12.2009

EU/1/97/045/001/NO-004/NO

Helicobacter Test INFAI

Norway

21.9.2009

EU/2/07/076/001-004/IS

Nobilis Influenza H5N6

Iceland

7.9.2009

EU/2/08/083/001/IS

Equioxx

Iceland

21.7.2009

EU/2/08/086/001-003/IS

Duvaxyn WNV

Iceland

4.11.2009

EU/2/09/095/001-003/IS

Improvac

Iceland

3.11.2009

EU/2/09/096/001-002/IS

Leucogen

Iceland

11.9.2009

EU/2/09/097/001/NO-002/NO

Leucofeligen FeLV/RCP

Norway

13.7.2009

EU/2/09/097/001-002

Leucofeligen FeLV/RCP

Liechtenstein

31.8.2009

EU/2/09/097/001-002/IS

Leucofeligen FeLV/RCP

Iceland

11.9.2009

EU/2/09/098/001

Melovem

Liechtenstein

31.8.2009

EU/2/09/098/001/IS

Melovem

Iceland

22.9.2009

EU/2/09/098/001/NO

Melovem

Norway

4.9.2009

EU/2/09/099/001/NO-006/NO

Suvaxyn PCV vet

Norway

18.8.2009

EU/2/09/099/001-006

Suvaxyn PCV

Liechtenstein

31.8.2009

EU/2/09/099/001-006/IS

Suvaxyn PCV

Iceland

28.9.2009

EU/2/09/100/001/NO-003/NO

Palladia

Norway

29.10.2009

EU/2/09/100/001-003

Palladia

Liechtenstein

31.10.2009

EU/2/09/100/001-003/IS

Palladia

Iceland

11.11.2009

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2009:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/03/264/001/NO | Zevalin | Norway | 21.8.2009 |
| EU/1/03/270/001/NO-003/NO | Kentera | Norway | 9.7.2009 |
| EU/1/04/275/001/NO-002/NO | Litak | Norway | 1.7.2009 |
| EU/1/04/276/001/NO-036/NO | Abilify | Norway | 13.7.2009 |
| EU/1/04/276/001-020,024-036/IS | Abilify | Iceland | 20.7.2009 |
| EU/1/04/277/001/NO-004/NO | Tachosil | Norway | 24.9.2009 |
| EU/1/04/277/001-004/IS | Tachosil | Iceland | 2.9.2009 |
| EU/1/04/279/001/NO-036/NO | Lyrica | Norway | 29.7.2009 |
| EU/1/04/279/001-025,030-043/IS | Lyrica | Iceland | 21.9.2009 |
| EU/1/04/280/001/NO-008/NO | Yentreve | Norway | 18.8.2009 |
| EU/1/04/280/001-008/IS | Yentreve | Iceland | 14.9.2009 |
| EU/1/04/280/001-008 | Yentreve | Liechtenstein | 31.8.2009 |
| EU/1/04/281/001-005/IS | Erbitux | Iceland | 9.9.2009 |
| EU/1/04/282/001/NO-002/NO | Telzir | Norway | 10.8.2009 |
| EU/1/04/282/001-002/IS | Telzir | Iceland | 21.7.2009 |
| EU/1/04/283/008/NO-012/NO | Ariclaim | Norway | 24.8.2009 |
| EU/1/04/283/008-012/IS | Ariclaim | Iceland | 14.9.2009 |
| EU/1/04/284/001 | Pedea | Liechtenstein | 31.8.2009 |
| EU/1/04/284/001/IS | Pedea | Iceland | 28.9.2009 |
| EU/1/04/284/001/NO | Pedea | Norway | 20.10.2009 |
| EU/1/04/285/001/NO-036/NO | Apidra | Norway | 9.9.2009 |
| EU/1/04/285/001-036 | Apidra | Liechtenstein | 31.8.2009 |
| EU/1/04/285/001-036/IS | Apidra | Iceland | 2.10.2009 |
| EU/1/04/286/001/NO-002/NO | Wilzin | Norway | 26.10.2009 |
| EU/1/04/286/001-002 | Wilzin | Liechtenstein | 31.10.2009 |
| EU/1/04/286/001-002/IS | Wilzin | Iceland | 18.11.2009 |
| EU/1/04/287/001/NO-006/NO | Osseor | Norway | 18.12.2009 |
| EU/1/04/287/001-006 | Osseor | Liechtenstein | 31.12.2009 |
| EU/1/04/287/001-006/IS | Osseor | Iceland | 29.11.2009 |
| EU/1/04/288/001/NO-006/NO | Protelos | Norway | 28.12.2009 |
| EU/1/04/288/001-006/IS | Protelos | Iceland | 29.11.2009 |
| EU/1/04/289/001/NO-002/NO | Angiox | Norway | 9.7.2009 |
| EU/1/04/289/001-002 | Angiox | Liechtenstein | 31.8.2009 |
| EU/1/04/289/001-002/IS | Angiox | Iceland | 9.12.2009 |
| EU/1/04/290/001-002 | Alimta | Liechtenstein | 31.10.2009 |
| EU/1/04/290/001-002/IS | Alimta | Iceland | 24.9.2009 |
| EU/1/04/292/001/NO-012/NO | Mimpara | Norway | 6.10.2009 |
| EU/1/04/292/001-012 | Mimpara | Liechtenstein | 31.10.2009 |
| EU/1/04/292/001-012/IS | Mimpara | Iceland | 12.11.2009 |
| EU/1/04/294/001/NO-028/NO | Emselex | Norway | 21.10.2009 |
| EU/1/04/294/001-028/IS | Emselex | Iceland | 5.11.2009 |
| EU/1/04/295/001 | Xagrid | Liechtenstein | 31.12.2009 |
| EU/1/04/295/001/NO | Xagrid | Norway | 16.12.2009 |
| EU/1/04/295/001/IS | Xagrid | Iceland | 10.12.2009 |
| EU/1/04/296/001/NO-009/NO | Cymbalta | Norway | 24.8.2009 |
| EU/1/04/296/001-009/IS | Cymbalta | Iceland | 14.9.2009 |
| EU/1/04/297/001/NO-006/NO | Xeristar | Norway | 27.10.2009 |
| EU/1/04/297/001-008/IS | Xeristar | Iceland | 14.9.2009 |
| EU/1/04/298/001-003/IS | Kivexa | Iceland | 17.12.2009 |
| EU/1/04/304/001-007 | Azilect | Liechtenstein | 31.10.2009 |
| EU/1/04/304/001-007/IS | Azilect | Iceland | 11.11.2009 |
| EU/1/06/367/001-012/IS | Diacomit | Iceland | 21.12.2009 |
| EU/1/07/423/001/NO-003/NO | Vectibix | Norway | 16.7.2009 |
| EU/1/07/436/001-002/IS | Isentress | Iceland | 27.8.2009 |
| EU/1/08/468/001 | Intelence | Liechtenstein | 31.8.2009 |
| EU/1/08/468/001/IS | Intelence | Iceland | 22.10.2009 |
| EU/1/08/468/001/NO | Intelence | Norway | 20.8.2009 |
| EU/1/09/288/001-006 | Protelos | Liechtenstein | 31.12.2009 |
| EU/1/09/555/002/NO | Alimta | Norway | 23.9.2009 |
| EU/1/97/044/001/NO-008/NO | Simponi | Norway | 20.10.2009 |
| EU/1/97/044/001/NO-008/NO | Tasmar | Norway | 20.10.2009 |
| EU/1/97/044/001-008 | Tasmar | Liechtenstein | 31.10.2009 |
| EU/1/97/044/001-008/IS | Tasmar | Iceland | 15.10.2009 |
| EU/1/99/100/001-003/IS | Cetrotide | Iceland | 30.11.2009 |
| EU/1/99/103/001/NO-004/NO | Refacto AF | Norway | 2.7.2009 |
| EU/1/99/107/001/NO-004/NO | Rebetol | Norway | 30.7.2009 |
| EU/1/99/108/001/NO-003/NO | Ferriprox | Norway | 6.10.2009 |
| EU/1/99/108/001-003 | Ferriprox | Liechtenstein | 31.10.2009 |
| EU/1/99/108/001-003/IS | Ferriprox | Iceland | 11.11.2009 |
| EU/1/99/109/001/NO-002/NO | Integrilin | Norway | 10.8.2009 |
| EU/1/99/109/001-002 | Integrilin | Liechtenstein | 31.8.2009 |
| EU/1/99/109/001-002/IS | Integrilin | Iceland | 30.9.2009 |
| EU/1/99/112/001/NO-002/NO | Ziagen | Norway | 26.8.2009 |
| EU/1/99/112/001-002/IS | Ziagen | Iceland | 12.7.2009 |
| EU/1/99/113/001-004 | Paxene | Liechtenstein | 31.8.2009 |
| EU/1/99/113/001-004/IS | Paxene | Iceland | 27.11.2009 |
| EU/1/99/114/001/NO-003/NO | Zeffix | Norway | 16.9.2009 |
| EU/1/99/114/001-003 | Zeffix | Liechtenstein | 31.10.2009 |
| EU/1/99/114/001-003/IS | Zeffix | Iceland | 15.10.2009 |
| EU/1/99/116/001/NO-005/NO | Remicade | Norway | 2.10.2009 |
| EU/1/99/116/001-005 | Remicade | Liechtenstein | 31.8.2009 |
| EU/1/99/116/001-005/IS | Remicade | Iceland | 8.9.2009 |
| EU/1/99/117/001/NO-002/NO | Synagis | Norway | 28.9.2009 |
| EU/1/99/117/001-002 | Synagis | Liechtenstein | 31.8.2009 |
| EU/1/99/117/001-002/IS | Synagis | Iceland | 22.10.2009 |
| EU/1/99/118/001/NO-009/NO | Arava | Norway | 5.10.2009 |
| EU/1/99/118/001-010 | Arava | Liechtenstein | 31.8.2009 |
| EU/1/99/118/001-010/IS | Arava | Iceland | 15.9.2009 |
| EU/1/99/119/001,003,005-015/IS | NovoRapid | Iceland | 26.8.2009 |
| EU/1/99/120/001/NO-004/NO | Ammonaps | Norway | 22.10.2009 |
| EU/1/99/120/001-004 | Ammonaps | Liechtenstein | 31.10.2009 |
| EU/1/99/120/001-004/IS | Ammonaps | Iceland | 17.11.2009 |
| EU/1/99/126/001-021/IS | Enbrel | Iceland | 21.12.2009 |
| EU/2/04/043/001/NO | Equilis StrepE | Norway | 30.7.2009 |
| EU/2/04/044/001/NO-010/NO | Aivlosin | Norway | 18.9.2009 |
| EU/2/04/044/001-010 | Aivlosin | Liechtenstein | 31.10.2009 |
| EU/2/04/044/001-010/IS | Aivlosin | Iceland | 7.10.2009 |
| EU/2/04/045/001-007/IS | Previcox | Iceland | 21.9.2009 |
| EU/2/04/046/001-003 | Nobivac Piro | Liechtenstein | 31.8.2009 |
| EU/2/04/046/001-003/IS | Nobivac Piro | Iceland | 23.9.2009 |
| EU/2/98/009/001-006/IS | Suvaxyn Aujeszky 783+O/W | Iceland | 5.11.2009 |
| EU/2/98/010/017-18,21-24/NO | Econor | Norway | 24.11.2009 |
| EU/2/99/014//001-012 | Stronghold | Liechtenstein | 31.10.2009 |
| EU/2/99/014/001-012/IS | Stronghold | Iceland | 16.12.2009 |
| EU/2/99/015/001-002 | Oxyglobin | Liechtenstein | 31.10.2009 |
| EU/2/99/015/001-002/IS | Oxyglobin | Iceland | 30.11.2009 |

EU-Number

Product

Country

Date of authorisation

EU/1/03/264/001/NO

Zevalin

Norway

21.8.2009

EU/1/03/270/001/NO-003/NO

Kentera

Norway

9.7.2009

EU/1/04/275/001/NO-002/NO

Litak

Norway

1.7.2009

EU/1/04/276/001/NO-036/NO

Abilify

Norway

13.7.2009

EU/1/04/276/001-020,024-036/IS

Abilify

Iceland

20.7.2009

EU/1/04/277/001/NO-004/NO

Tachosil

Norway

24.9.2009

EU/1/04/277/001-004/IS

Tachosil

Iceland

2.9.2009

EU/1/04/279/001/NO-036/NO

Lyrica

Norway

29.7.2009

EU/1/04/279/001-025,030-043/IS

Lyrica

Iceland

21.9.2009

EU/1/04/280/001/NO-008/NO

Yentreve

Norway

18.8.2009

EU/1/04/280/001-008/IS

Yentreve

Iceland

14.9.2009

EU/1/04/280/001-008

Yentreve

Liechtenstein

31.8.2009

EU/1/04/281/001-005/IS

Erbitux

Iceland

9.9.2009

EU/1/04/282/001/NO-002/NO

Telzir

Norway

10.8.2009

EU/1/04/282/001-002/IS

Telzir

Iceland

21.7.2009

EU/1/04/283/008/NO-012/NO

Ariclaim

Norway

24.8.2009

EU/1/04/283/008-012/IS

Ariclaim

Iceland

14.9.2009

EU/1/04/284/001

Pedea

Liechtenstein

31.8.2009

EU/1/04/284/001/IS

Pedea

Iceland

28.9.2009

EU/1/04/284/001/NO

Pedea

Norway

20.10.2009

EU/1/04/285/001/NO-036/NO

Apidra

Norway

9.9.2009

EU/1/04/285/001-036

Apidra

Liechtenstein

31.8.2009

EU/1/04/285/001-036/IS

Apidra

Iceland

2.10.2009

EU/1/04/286/001/NO-002/NO

Wilzin

Norway

26.10.2009

EU/1/04/286/001-002

Wilzin

Liechtenstein

31.10.2009

EU/1/04/286/001-002/IS

Wilzin

Iceland

18.11.2009

EU/1/04/287/001/NO-006/NO

Osseor

Norway

18.12.2009

EU/1/04/287/001-006

Osseor

Liechtenstein

31.12.2009

EU/1/04/287/001-006/IS

Osseor

Iceland

29.11.2009

EU/1/04/288/001/NO-006/NO

Protelos

Norway

28.12.2009

EU/1/04/288/001-006/IS

Protelos

Iceland

29.11.2009

EU/1/04/289/001/NO-002/NO

Angiox

Norway

9.7.2009

EU/1/04/289/001-002

Angiox

Liechtenstein

31.8.2009

EU/1/04/289/001-002/IS

Angiox

Iceland

9.12.2009

EU/1/04/290/001-002

Alimta

Liechtenstein

31.10.2009

EU/1/04/290/001-002/IS

Alimta

Iceland

24.9.2009

EU/1/04/292/001/NO-012/NO

Mimpara

Norway

6.10.2009

EU/1/04/292/001-012

Mimpara

Liechtenstein

31.10.2009

EU/1/04/292/001-012/IS

Mimpara

Iceland

12.11.2009

EU/1/04/294/001/NO-028/NO

Emselex

Norway

21.10.2009

EU/1/04/294/001-028/IS

Emselex

Iceland

5.11.2009

EU/1/04/295/001

Xagrid

Liechtenstein

31.12.2009

EU/1/04/295/001/NO

Xagrid

Norway

16.12.2009

EU/1/04/295/001/IS

Xagrid

Iceland

10.12.2009

EU/1/04/296/001/NO-009/NO

Cymbalta

Norway

24.8.2009

EU/1/04/296/001-009/IS

Cymbalta

Iceland

14.9.2009

EU/1/04/297/001/NO-006/NO

Xeristar

Norway

27.10.2009

EU/1/04/297/001-008/IS

Xeristar

Iceland

14.9.2009

EU/1/04/298/001-003/IS

Kivexa

Iceland

17.12.2009

EU/1/04/304/001-007

Azilect

Liechtenstein

31.10.2009

EU/1/04/304/001-007/IS

Azilect

Iceland

11.11.2009

EU/1/06/367/001-012/IS

Diacomit

Iceland

21.12.2009

EU/1/07/423/001/NO-003/NO

Vectibix

Norway

16.7.2009

EU/1/07/436/001-002/IS

Isentress

Iceland

27.8.2009

EU/1/08/468/001

Intelence

Liechtenstein

31.8.2009

EU/1/08/468/001/IS

Intelence

Iceland

22.10.2009

EU/1/08/468/001/NO

Intelence

Norway

20.8.2009

EU/1/09/288/001-006

Protelos

Liechtenstein

31.12.2009

EU/1/09/555/002/NO

Alimta

Norway

23.9.2009

EU/1/97/044/001/NO-008/NO

Simponi

Norway

20.10.2009

EU/1/97/044/001/NO-008/NO

Tasmar

Norway

20.10.2009

EU/1/97/044/001-008

Tasmar

Liechtenstein

31.10.2009

EU/1/97/044/001-008/IS

Tasmar

Iceland

15.10.2009

EU/1/99/100/001-003/IS

Cetrotide

Iceland

30.11.2009

EU/1/99/103/001/NO-004/NO

Refacto AF

Norway

2.7.2009

EU/1/99/107/001/NO-004/NO

Rebetol

Norway

30.7.2009

EU/1/99/108/001/NO-003/NO

Ferriprox

Norway

6.10.2009

EU/1/99/108/001-003

Ferriprox

Liechtenstein

31.10.2009

EU/1/99/108/001-003/IS

Ferriprox

Iceland

11.11.2009

EU/1/99/109/001/NO-002/NO

Integrilin

Norway

10.8.2009

EU/1/99/109/001-002

Integrilin

Liechtenstein

31.8.2009

EU/1/99/109/001-002/IS

Integrilin

Iceland

30.9.2009

EU/1/99/112/001/NO-002/NO

Ziagen

Norway

26.8.2009

EU/1/99/112/001-002/IS

Ziagen

Iceland

12.7.2009

EU/1/99/113/001-004

Paxene

Liechtenstein

31.8.2009

EU/1/99/113/001-004/IS

Paxene

Iceland

27.11.2009

EU/1/99/114/001/NO-003/NO

Zeffix

Norway

16.9.2009

EU/1/99/114/001-003

Zeffix

Liechtenstein

31.10.2009

EU/1/99/114/001-003/IS

Zeffix

Iceland

15.10.2009

EU/1/99/116/001/NO-005/NO

Remicade

Norway

2.10.2009

EU/1/99/116/001-005

Remicade

Liechtenstein

31.8.2009

EU/1/99/116/001-005/IS

Remicade

Iceland

8.9.2009

EU/1/99/117/001/NO-002/NO

Synagis

Norway

28.9.2009

EU/1/99/117/001-002

Synagis

Liechtenstein

31.8.2009

EU/1/99/117/001-002/IS

Synagis

Iceland

22.10.2009

EU/1/99/118/001/NO-009/NO

Arava

Norway

5.10.2009

EU/1/99/118/001-010

Arava

Liechtenstein

31.8.2009

EU/1/99/118/001-010/IS

Arava

Iceland

15.9.2009

EU/1/99/119/001,003,005-015/IS

NovoRapid

Iceland

26.8.2009

EU/1/99/120/001/NO-004/NO

Ammonaps

Norway

22.10.2009

EU/1/99/120/001-004

Ammonaps

Liechtenstein

31.10.2009

EU/1/99/120/001-004/IS

Ammonaps

Iceland

17.11.2009

EU/1/99/126/001-021/IS

Enbrel

Iceland

21.12.2009

EU/2/04/043/001/NO

Equilis StrepE

Norway

30.7.2009

EU/2/04/044/001/NO-010/NO

Aivlosin

Norway

18.9.2009

EU/2/04/044/001-010

Aivlosin

Liechtenstein

31.10.2009

EU/2/04/044/001-010/IS

Aivlosin

Iceland

7.10.2009

EU/2/04/045/001-007/IS

Previcox

Iceland

21.9.2009

EU/2/04/046/001-003

Nobivac Piro

Liechtenstein

31.8.2009

EU/2/04/046/001-003/IS

Nobivac Piro

Iceland

23.9.2009

EU/2/98/009/001-006/IS

Suvaxyn Aujeszky 783+O/W

Iceland

5.11.2009

EU/2/98/010/017-18,21-24/NO

Econor

Norway

24.11.2009

EU/2/99/014//001-012

Stronghold

Liechtenstein

31.10.2009

EU/2/99/014/001-012/IS

Stronghold

Iceland

16.12.2009

EU/2/99/015/001-002

Oxyglobin

Liechtenstein

31.10.2009

EU/2/99/015/001-002/IS

Oxyglobin

Iceland

30.11.2009

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2009:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/146/031-032 | Keppra | Liechtenstein | 31.10.2009 |
| EU/1/00/155/007/IS | Luveris | Iceland | 22.7.2009 |
| EU/1/00/155/007/NO | Luveris | Norway | 12.8.2009 |
| EU/1/01/185/074-099 | Aranesp | Liechtenstein | 31.12.2009 |
| EU/1/01/195/022/NO-025/NO | Liprolog Basal | Norway | 13.8.2009 |
| EU/1/01/195/026/NO-027/NO | Liprolog Basal Kwik-Pen | Norway | 13.8.2009 |
| EU/1/02/220/006 | Tracleer | Liechtenstein | 31.8.2009 |
| EU/1/02/220/006/IS | Tracleer | Iceland | 16.9.2009 |
| EU/1/02/227/004 | Neulasta | Liechtenstein | 31.10.2009 |
| EU/1/05/315/002/IS | Aptivus | Iceland | 26.8.2009 |
| EU/1/05/315/002/NO | Aptivus | Norway | 12.8.2009 |
| EU/1/06/347/007/NO-008/NO | Sutent | Norway | 7.9.2009 |
| EU/1/06/347/007-008/IS | Sutent | Iceland | 9.9.2009 |
| EU/1/06/380/004/NO-005/NO | Prezista | Norway | 12.8.2009 |
| EU/1/06/380/004-005/IS | Prezista | Iceland | 10.9.2009 |
| EU/1/07/384/003-004/IS | Docetaxel Winthrop | Iceland | 28.12.2009 |
| EU/1/07/410/021/NO-026/NO | Binocrit | Norway | 27.10.2009 |
| EU/1/07/410/021-026 | Binocrit | Liechtenstein | 31.10.2009 |
| EU/1/07/410/021-026/IS | Binocrit | Iceland | 15.10.2009 |
| EU/1/07/411/021/NO-026/NO | Epoetin alfa Hexal | Norway | 23.10.2009 |
| EU/1/07/411/021-026 | Epoetin alfa Hexal | Liechtenstein | 31.10.2009 |
| EU/1/07/412/021-026/IS | Abseamed | Iceland | 21.12.2009 |
| EU/1/07/416/002 | Ecalta | Liechtenstein | 31.8.2009 |
| EU/1/07/416/002/IS | Ecalta | Iceland | 25.9.2009 |
| EU/1/07/416/002/NO | Ecalta | Norway | 25.8.2009 |
| EU/1/08/446/005-006 | Privigen | Liechtenstein | 31.8.2009 |
| EU/1/08/453/002 | Prepandrix | Liechtenstein | 31.8.2009 |
| EU/1/08/453/002/IS | Prepandrix | Iceland | 9.11.2009 |
| EU/1/08/489/002 | Opgenra | Liechtenstein | 31.10.2009 |
| EU/1/08/497/003-004 | Nplate | Liechtenstein | 31.10.2009 |
| EU/1/95/002/003-004/IS | Taxotere | Iceland | 23.12.2009 |
| EU/1/95/003/009-010 | Betaferon | Liechtenstein | 31.10.2009 |
| EU/1/97/050/013/NO-027/NO | Sifrol | Norway | 20.10.2009 |
| EU/1/97/050/013-027 | Sifrol | Liechtenstein | 31.10.2009 |
| EU/1/97/050/013-027/IS | Sifrol | Iceland | 12.11.2009 |
| EU/1/97/051/013/NO-027/NO | Mirapexin | Norway | 22.10.2009 |
| EU/1/97/051/013-027 | Mirapexin | Liechtenstein | 31.10.2009 |
| EU/1/97/051/013-027/IS | Mirapexin | Iceland | 12.11.2009 |
| EU/1/99/126/019-021 | Enbrel | Liechtenstein | 31.8.2009 |
| EU/2/04/044/009/NO-010/NO | Aivlosin | Norway | 15.7.2009 |
| EU/2/04/044/009-010/IS | Aivlosin | Iceland | 2.9.2009 |
| EU/2/05/053/003 | Naxcel | Liechtenstein | 31.10.2009 |
| EU/2/05/053/003/IS | Naxcel | Iceland | 13.11.2009 |
| EU/2/05/053/003/NO | Naxcel | Norway | 26.10.2009 |
| EU/2/06/070/004 | Meloxidyl | Liechtenstein | 31.10.2009 |
| EU/2/06/070/004/NO | Meloxidyl | Norway | 20.10.2009 |
| EU/2/07/078/004-006 | Zactran | Liechtenstein | 31.8.2009 |
| EU/2/07/078/005/NO-008/NO | Rheumocam | Norway | 26.10.2009 |
| EU/2/07/078/005-008/IS | Rheumocam | Iceland | 13.11.2009 |
| EU/2/078/005-008 | Rheumocam | Liechtenstein | 31.10.2009 |
| EU/2/98/010/004/NO-006/NO | Econor | Norway | 24.11.2009 |

EU-Number

Product

Country

Date of authorisation

EU/1/00/146/031-032

Keppra

Liechtenstein

31.10.2009

EU/1/00/155/007/IS

Luveris

Iceland

22.7.2009

EU/1/00/155/007/NO

Luveris

Norway

12.8.2009

EU/1/01/185/074-099

Aranesp

Liechtenstein

31.12.2009

EU/1/01/195/022/NO-025/NO

Liprolog Basal

Norway

13.8.2009

EU/1/01/195/026/NO-027/NO

Liprolog Basal Kwik-Pen

Norway

13.8.2009

EU/1/02/220/006

Tracleer

Liechtenstein

31.8.2009

EU/1/02/220/006/IS

Tracleer

Iceland

16.9.2009

EU/1/02/227/004

Neulasta

Liechtenstein

31.10.2009

EU/1/05/315/002/IS

Aptivus

Iceland

26.8.2009

EU/1/05/315/002/NO

Aptivus

Norway

12.8.2009

EU/1/06/347/007/NO-008/NO

Sutent

Norway

7.9.2009

EU/1/06/347/007-008/IS

Sutent

Iceland

9.9.2009

EU/1/06/380/004/NO-005/NO

Prezista

Norway

12.8.2009

EU/1/06/380/004-005/IS

Prezista

Iceland

10.9.2009

EU/1/07/384/003-004/IS

Docetaxel Winthrop

Iceland

28.12.2009

EU/1/07/410/021/NO-026/NO

Binocrit

Norway

27.10.2009

EU/1/07/410/021-026

Binocrit

Liechtenstein

31.10.2009

EU/1/07/410/021-026/IS

Binocrit

Iceland

15.10.2009

EU/1/07/411/021/NO-026/NO

Epoetin alfa Hexal

Norway

23.10.2009

EU/1/07/411/021-026

Epoetin alfa Hexal

Liechtenstein

31.10.2009

EU/1/07/412/021-026/IS

Abseamed

Iceland

21.12.2009

EU/1/07/416/002

Ecalta

Liechtenstein

31.8.2009

EU/1/07/416/002/IS

Ecalta

Iceland

25.9.2009

EU/1/07/416/002/NO

Ecalta

Norway

25.8.2009

EU/1/08/446/005-006

Privigen

Liechtenstein

31.8.2009

EU/1/08/453/002

Prepandrix

Liechtenstein

31.8.2009

EU/1/08/453/002/IS

Prepandrix

Iceland

9.11.2009

EU/1/08/489/002

Opgenra

Liechtenstein

31.10.2009

EU/1/08/497/003-004

Nplate

Liechtenstein

31.10.2009

EU/1/95/002/003-004/IS

Taxotere

Iceland

23.12.2009

EU/1/95/003/009-010

Betaferon

Liechtenstein

31.10.2009

EU/1/97/050/013/NO-027/NO

Sifrol

Norway

20.10.2009

EU/1/97/050/013-027

Sifrol

Liechtenstein

31.10.2009

EU/1/97/050/013-027/IS

Sifrol

Iceland

12.11.2009

EU/1/97/051/013/NO-027/NO

Mirapexin

Norway

22.10.2009

EU/1/97/051/013-027

Mirapexin

Liechtenstein

31.10.2009

EU/1/97/051/013-027/IS

Mirapexin

Iceland

12.11.2009

EU/1/99/126/019-021

Enbrel

Liechtenstein

31.8.2009

EU/2/04/044/009/NO-010/NO

Aivlosin

Norway

15.7.2009

EU/2/04/044/009-010/IS

Aivlosin

Iceland

2.9.2009

EU/2/05/053/003

Naxcel

Liechtenstein

31.10.2009

EU/2/05/053/003/IS

Naxcel

Iceland

13.11.2009

EU/2/05/053/003/NO

Naxcel

Norway

26.10.2009

EU/2/06/070/004

Meloxidyl

Liechtenstein

31.10.2009

EU/2/06/070/004/NO

Meloxidyl

Norway

20.10.2009

EU/2/07/078/004-006

Zactran

Liechtenstein

31.8.2009

EU/2/07/078/005/NO-008/NO

Rheumocam

Norway

26.10.2009

EU/2/07/078/005-008/IS

Rheumocam

Iceland

13.11.2009

EU/2/078/005-008

Rheumocam

Liechtenstein

31.10.2009

EU/2/98/010/004/NO-006/NO

Econor

Norway

24.11.2009

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2009:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/01/175/001-021/IS | Trazec | Iceland | 15.12.2009 |
| EU/1/05/321/001/IS | Posaconazole SP | Iceland | 15.12.2009 |
| EU/1/06/369/001/NO-028/NO | Irbesartan BMS | Norway | 1.12.2009 |
| EU/1/06/369/001/NO-028/NO | Irbesartan HCT BMS | Norway | 1.12.2009 |
| EU/1/06/369/001/NO-028/NO | Irbesartan BMS | Norway | 1.12.2009 |
| EU/1/06/369/001/NO-028/NO | Irbesartan HCT BMS | Norway | 1.12.2009 |
| EU/1/06/369/001-028 | Irbesartan HCT BMS | Liechtenstein | 31.12.2009 |
| EU/1/06/369/001-028/IS | Irbesartan HCT BMS | Iceland | 2.12.2009 |
| EU/1/06/375/001-033/IS | Irbesartan BMS | Iceland | 2.12.2009 |
| EU/1/07/385/003/NO | Focetria | Norway | 19.10.2009 |
| EU/1/07/408/001/NO-020/NO | Tekturna | Norway | 17.9.2009 |
| EU/1/07/408/001-020 | Tekturna | Liechtenstein | 31.10.2009 |
| EU/1/07/408/001-020/IS | Tekturna | Iceland | 2.9.2009 |
| EU/1/08/464/001/NO-019/NO | Clopidogrel BMS | Norway | 22.12.2009 |
| EU/1/08/464/001-019/IS | Clopidogrel BMS | Iceland | 2.12.2009 |
| EU/1/08/464/001-019 | Clopidogrel BMS | Liechtenstein | 31.12.2009 |
| EU/1/96/024/006NO,007/NO,009/NO | Crixivan | Norway | 24.9.2009 |
| EU/1/96/024/006NO,007/NO,009/NO | Crixivan | Norway | 24.9.2009 |
| EU/1/99/104/001/IS | Procomvax | Iceland | 15.12.2009 |
| EU/1/99/113/001-004/IS | Paxene | Iceland | 2.12.2009 |

EU-Number

Product

Country

Date of withdrawal

EU/1/01/175/001-021/IS

Trazec

Iceland

15.12.2009

EU/1/05/321/001/IS

Posaconazole SP

Iceland

15.12.2009

EU/1/06/369/001/NO-028/NO

Irbesartan BMS

Norway

1.12.2009

EU/1/06/369/001/NO-028/NO

Irbesartan HCT BMS

Norway

1.12.2009

EU/1/06/369/001/NO-028/NO

Irbesartan BMS

Norway

1.12.2009

EU/1/06/369/001/NO-028/NO

Irbesartan HCT BMS

Norway

1.12.2009

EU/1/06/369/001-028

Irbesartan HCT BMS

Liechtenstein

31.12.2009

EU/1/06/369/001-028/IS

Irbesartan HCT BMS

Iceland

2.12.2009

EU/1/06/375/001-033/IS

Irbesartan BMS

Iceland

2.12.2009

EU/1/07/385/003/NO

Focetria

Norway

19.10.2009

EU/1/07/408/001/NO-020/NO

Tekturna

Norway

17.9.2009

EU/1/07/408/001-020

Tekturna

Liechtenstein

31.10.2009

EU/1/07/408/001-020/IS

Tekturna

Iceland

2.9.2009

EU/1/08/464/001/NO-019/NO

Clopidogrel BMS

Norway

22.12.2009

EU/1/08/464/001-019/IS

Clopidogrel BMS

Iceland

2.12.2009

EU/1/08/464/001-019

Clopidogrel BMS

Liechtenstein

31.12.2009

EU/1/96/024/006NO,007/NO,009/NO

Crixivan

Norway

24.9.2009

EU/1/96/024/006NO,007/NO,009/NO

Crixivan

Norway

24.9.2009

EU/1/99/104/001/IS

Procomvax

Iceland

15.12.2009

EU/1/99/113/001-004/IS

Paxene

Iceland

2.12.2009

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2009:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| None | None | — | — |

EU-Number

Product

Country

Date of suspension

None

None

—

—

---